Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology total assets
Total assets on the balance sheet at the end of each period.
Regenerative Medical Technology's total assets was $5.85M at Jun 30, 2026. For fiscal 2025 it was $4.49M, up 17.5% from the year before. The highest annual figure on record is $9.31M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.49M | +17.5% |
| FY2024 | Dec 31, 2024 | $3.82M | +32.7% |
| FY2023 | Dec 31, 2023 | $2.88M | -64.4% |
| FY2022 | Dec 31, 2022 | $8.08M | -13.2% |
| FY2021 | Dec 31, 2021 | $9.31M | +4134.9% |
| FY2020 | Dec 31, 2020 | $219.73K | +733.0% |
| FY2019 | Dec 31, 2019 | $26.38K | -23.8% |
| FY2018 | Dec 31, 2018 | $34.63K | +340.7% |
| FY2017 | Dec 31, 2017 | $7.86K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.85M | +30.4% |
| Q1 FY2026 | Mar 31, 2026 | $5.01M | +25.8% |
| Q4 FY2025 | Dec 31, 2025 | $4.49M | +17.5% |
| Q3 FY2025 | Sep 30, 2025 | $4.52M | +40.0% |
| Q2 FY2025 | Jun 30, 2025 | $4.49M | +47.1% |
| Q1 FY2025 | Mar 31, 2025 | $3.98M | +29.3% |
| Q4 FY2024 | Dec 31, 2024 | $3.82M | +32.7% |
| Q3 FY2024 | Sep 30, 2024 | $3.23M | -2.6% |
| Q2 FY2024 | Jun 30, 2024 | $3.05M | -59.6% |
| Q1 FY2024 | Mar 31, 2024 | $3.08M | -61.8% |
| Q4 FY2023 | Dec 31, 2023 | $2.88M | -64.4% |
| Q3 FY2023 | Sep 30, 2023 | $3.31M | -59.7% |
| Q2 FY2023 | Jun 30, 2023 | $7.54M | -9.9% |
| Q1 FY2023 | Mar 31, 2023 | $8.07M | -9.9% |
| Q4 FY2022 | Dec 31, 2022 | $8.08M | -13.2% |
| Q3 FY2022 | Sep 30, 2022 | $8.23M | -51.8% |
| Q2 FY2022 | Jun 30, 2022 | $8.37M | -23.4% |
| Q1 FY2022 | Mar 31, 2022 | $8.96M | +828.5% |
| Q4 FY2021 | Dec 31, 2021 | $9.31M | +4134.9% |
| Q3 FY2021 | Sep 30, 2021 | $17.07M | +7104.5% |
| Q2 FY2021 | Jun 30, 2021 | $10.92M | +16917.8% |
| Q1 FY2021 | Mar 31, 2021 | $964.67K | +6743.1% |
| Q4 FY2020 | Dec 31, 2020 | $219.73K | +733.0% |
| Q3 FY2020 | Sep 30, 2020 | $236.87K | +7238.1% |
| Q2 FY2020 | Jun 30, 2020 | $64.17K | +47.4% |
| Q1 FY2020 | Mar 31, 2020 | $14.10K | +237.4% |
| Q4 FY2019 | Dec 31, 2019 | $26.38K | -23.8% |
| Q3 FY2019 | Sep 30, 2019 | $3.23K | -58.9% |
| Q2 FY2019 | Jun 30, 2019 | $43.55K | – |
| Q1 FY2019 | Mar 31, 2019 | $4.18K | – |
| Q4 FY2018 | Dec 31, 2018 | $34.63K | – |
| Q4 FY2017 | Dec 31, 2017 | $7.86K | – |
See a number that looks wrong?